Quality of Life and Psychological Strengths of Older People
QUALIFRAG
1 other identifier
interventional
110
1 country
1
Brief Summary
Older adults have psychological strengths that promote psychological well-being and reduce distress (depression or anxiety) and loneliness, enhancing their quality of life (QoL). These strengths can play a key role in a psychological intervention programme to promote QoL. Ageing and stress may increase the likelihood of illness in older people. When social policies and values, such as ageism and age-based discrimination, are added to this, older people are perceived as one of the most vulnerable groups in the population. The novelty of the study focuses on the paradigm shift regarding ageing, from the traditional model of decline associated with older people, in which ageing is associated with illness, functional decline and dependence, to a more positive view focused on personal strengths to cope with adversity, and how this relates to psychological well-being, emotional distress and QoL. The first and main reason for conducting this research is the scarcity of studies based on the model of strengths or gains in relation to ageing. Therefore, the relevance of this study lies, on the one hand, in offering a change of perspective on old age, from a negative view (illness or vulnerability) to an approach based on strengths, and on the other hand, in gaining a deeper understanding of the strengths of older people, the associated factors and the role they play in cushioning adversity, such as in the COVID-19 pandemic. Most older people remain healthy, independent and enjoy high levels of well-being and QoL, with factors such as resilience cushioning the consequences of stress and ageing. In this vein, it has been shown that age strengthens the ability to distance oneself from stressful situations and re-evaluate them positively, and older people report greater emotional well-being compared to younger adults. Furthermore, it is well known that having good social support seems to have long-term health benefits. Some recent studies related to the pandemic show that older people, despite being the most threatened by the situation, had lower levels of anxiety and depression compared to younger people, contrary to expectations. Furthermore, coping strategies, such as resilience and social support, are mediating factors in the well-being of older people exposed to COVID-19. Psychology, and psychogerontology in particular, is responsible for designing interventions aimed at increasing the likelihood of successful ageing. In fact, managing emotions is essential for people's health, well-being and QoL. In this sense, the emergence of positive psychology represents a change in therapeutic and rehabilitation processes. This psychological trend leaves behind a model based mainly on negative aspects and loss, in order to enhance human qualities that can act as buffers against adversity. In this way, a shift in focus is established, suggesting that in addition to trying to alleviate pathological aspects, it is equally important to find people's qualities or virtues in order to achieve greater QoL. COVID-19 has led to older people being portrayed as a homogeneous group, even though increased life expectancy means that this is the longest stage of life, with studies reflecting the great diversity of older people. They are repeatedly portrayed as vulnerable, with messages that convey paternalism ('our elders') and overprotection, despite scientific literature indicating that this can have serious consequences. Throughout their lives, older people have had to face adversity, which they have been able to overcome or accept thanks to psychological strengths such as resilience, acceptance and gratitude, among others.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable quality-of-life
Started Sep 2023
Longer than P75 for not_applicable quality-of-life
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2023
CompletedFirst Submitted
Initial submission to the registry
December 11, 2023
CompletedFirst Posted
Study publicly available on registry
April 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2026
ExpectedNovember 21, 2025
November 1, 2025
2.4 years
December 11, 2023
November 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Quality of life
Quality of life will be evaluated with Quality of Life Questionnaire for the Elderly (CASP-12) Scale values: 1 (sometimes), 2, 3, 4 (never). Interpretation: the higher the score, the greater the quality of life of the person being assessed.
Through study completion, and average of 4 years.
Psychological wellbeing
Psychological wellbeing will be evaluated with Ryff's Psychological Wellbeing Scale. Scale values: 1 (very inadequate to describe me), 2 (quite inadequate to describe me), 3 (some inadequate to describe me), 4 (some adequate to describe me), 5 (quite adequate to describe me), 6 (very adequate to describe me). Interpretation: the higher the score, the greater the psychological wellbeing of the person being assessed.
Through study completion, and average of 4 years.
Loneliness
Loneliness will be evaluated with Three-Item Loneliness Scale. Scale values: 1 (hardly ever, 2 (some of the time), 3 (often). Interpretation: the higher the score, the greater the loneliness of the person being assessed.
Through study completion, and average of 4 years.
Anxiety and depression Anxiety and depression
Anxiety and depression will be evaluated with Hospital Anxiety and Depression Scale. Scale values: values 2-4. The meaning of the values are different for each item. Interpretation: the higher the score, the greater the anxiety and depression of the person being assessed.
Through study completion, and average of 4 years.
Gratitude
Gratitude will be evaluated with the short form of the Values in Action Inventory of Strengths (VIA-IS). Scale values: 1 (very different from me), 2 (somewhat different from me), 3 (neutral), 4 (somewhat similar to me), 5 (very similar to me). Interpretation: the higher the score, the greater the gratitude of the person being assessed.
Through study completion, and average of 4 years.
Experiential acceptance
Experiential acceptance will be evaluated with the Acceptance and Action Questionnaire II. Scale values: 1 (never true), 2 (very seldom true), 3 (seldom true), 4 (sometimes true), 5 (frequently true), 6 (almost always true), 7 (always true). Interpretation: the higher the score, the greater the experiential acceptance of the person being assessed.
Through study completion, and average of 4 years.
Resilience
Resilience will be evaluated with the Brief Resilient Coping Scale (BRCS). Scale values: 1 (it does not reflect a typical reaction in my), 2, 3, 4, 5 (it does reflect a typical reaction in my). Interpretation: the higher the score, the greater the resilience of the person being assessed.
Through study completion, and average of 4 years.
Family functioning
Family functioning will be evaluated with the APGAR familiar. Scale values:0 (never), 1 (rarely), 2 (sometimes), 3 (almost always), 4 (always). Interpretation: the higher the score, the greater the family functioning of the person being assessed.
Through study completion, and average of 4 years.
Study Arms (2)
Experimental group
EXPERIMENTALThe experimental group is given the workshop "How to improve your strengths and quality of life".
Control group
NO INTERVENTIONThe control group is not given the workshop "How to improve your strengths and quality of life".
Interventions
The intervention program "How to improve your strengths and quality of life" consists of 9 individual sessions. The sessions take place weekly, so the total duration of the program is 9 weeks. Each session lasts approximately 1 hour. The sessions will be held both in person and online. The sessions are as follows: * Session 0. Presentation of the programme * Session 1. Introduction to quality of life and personal strengths * Session 2. Self-realisation * Session 3. Pleasure and gratitude * Session 4. Autonomy and control * Session 5. Family functioning and assertive communication * Session 6. Resilience * Session 7. Experiential acceptance * Session 8. Closing and farewell
Eligibility Criteria
You may qualify if:
- Be at least 60 years of age.
- Residing in Spain.
- Not having a diagnosed neurological disease or severe psychopathological disorder, or other ailment that is incompatible with the understanding of the questionnaires or the intervention program.
- Acceptance and signature of the informed consent.
You may not qualify if:
- Do not comply with the established age range.
- Present an ailment that makes them unable to respond to the questionnaire.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
San Pablo CEU University (Campus Montepríncipe)
Alcorcón, Madrid, 28925, Spain
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 11, 2023
First Posted
April 24, 2024
Study Start
September 1, 2023
Primary Completion
January 31, 2026
Study Completion (Estimated)
August 31, 2026
Last Updated
November 21, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data will be available from August 2026.